|
1
|
Lee L, Fei L, Pope J and Wagner LM: Early
lymphocyte recovery and outcome in osteosarcoma. J Pediatr Hematol
Oncol. 39:179–183. 2017. View Article : Google Scholar
|
|
2
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004: Data
from the surveillance, epidemiology, and end results program.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cam M, Gardner HL, Roberts RD, Fenger JM,
Guttridge DC, London CA and Cam H: ∆Np63 mediates cellular survival
and metastasis in canine osteosarcoma. Oncotarget. 7:48533–48546.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Cao L, Wang J and Wang PQ: MiR-326 is a
diagnostic biomarker and regulates cell survival and apoptosis by
targeting Bcl-2 in osteosarcoma. Biomed Pharmacother. 84:828–835.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tu B, Zhu J, Liu S, Wang L, Fan Q, Hao Y,
Fan C and Tang TT: Mesenchymal stem cells promote osteosarcoma cell
survival and drug resistance through activation of STAT3.
Oncotarget. 7:48296–48308. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhou Y, Lu Q, Xu J, Yan R, Zhu J, Xu J,
Jiang X, Li J and Wu F: The effect of pathological fractures on the
prognosis of patients with osteosarcoma: A meta-analysis of 14
studies. Oncotarget. 8:73037–73049. 2017.PubMed/NCBI
|
|
7
|
Li YJ, Yao K, Lu MX, Zhang WB, Xiao C and
Tu CQ: Prognostic value of the C-reactive protein to albumin ratio:
A novel inflammation-based prognostic indicator in osteosarcoma.
Onco Targets Ther. 10:5255–5261. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Wang XX, Liao Y, Hong L, Zeng Z, Yuan TB,
Xia X and Qin J: Tissue microarray staining reveals PLD1 and Sp1
have a collaborative, pro-tumoral effect in patients with
osteosarcomas. Oncotarget. 8:74340–74347. 2017.PubMed/NCBI
|
|
9
|
Chen YM, Shen QC, Gokavarapu S, Ong HS,
Cao W and Ji T: Osteosarcoma of the Mandible: A site-specific study
on survival and prognostic factors. J Craniofac Surg. 27:1929–1933.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li Z, Dou P, Liu T and He S: Application
of long Noncoding RNAs in osteosarcoma: Biomarkers and therapeutic
targets. Cell Physiol Biochem. 42:1407–1419. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Simpson S, Dunning MD, de Brot S,
Grau-Roma L, Mongan NP and Rutland CS: Comparative review of human
and canine osteosarcoma: Morphology, epidemiology, prognosis,
treatment and genetics. Acta Vet Scand. 59:712017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Wang Y, Zhang Y, Yang T, Zhao W, Wang N,
Li P, Zeng X and Zhang W: Long non-coding RNA MALAT1 for promoting
metastasis and proliferation by acting as a ceRNA of miR-144 3p in
osteosarcoma cells. Oncotarget. 8:59417–59434. 2017.PubMed/NCBI
|
|
13
|
Gao S, Cheng C, Chen H, Li M, Liu K and
Wang G: IGF1 3’UTR functions as a ceRNA in promoting angiogenesis
by sponging miR-29 family in osteosarcoma. J Mol Histol.
47:135–143. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang Y, Yang T, Zhang Z, Lu M, Zhao W,
Zeng X and Zhang W: Long non-coding RNA TUG1 promotes migration and
invasion by acting as a ceRNA of miR-335-5p in osteosarcoma cells.
Cancer Sci. 108:859–867. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kelly AD, Haibe-Kains B, Janeway KA, Hill
KE, Howe E, Goldsmith J, Kurek K, Perez-Atayde AR, Francoeur N, Fan
JB, et al: MicroRNA paraffin-based studies in osteosarcoma reveal
reproducible independent prognostic profiles at 14q32. Genome Med.
5:22013. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Vlachos IS, Paraskevopoulou MD, Karagkouni
D, Georgakilas G, Vergoulis T, Kanellos I, Anastasopoulos IL,
Maniou S, Karathanou K, Kalfakakou D, et al: DIANA-TarBase v7.0:
Indexing more than half a million experimentally supported miRNA:
mRNA interactions. Nucleic Acids Res. 43(Database issue):
D153–D159. 2015. View Article : Google Scholar
|
|
17
|
Hsu SD, Tseng YT, Shrestha S, Lin YL,
Khaleel A, Chou CH, Chu CF, Huang HY, Lin CM, Ho SY, et al:
miRTarBase update 2014: An information resource for experimentally
validated miRNA-target interactions. Nucleic Acids Res. 42(Database
issue): D78–D85. 2014. View Article : Google Scholar :
|
|
18
|
Xiao F, Zuo Z, Cai G, Kang S, Gao X and Li
T: miRecords: An integrated resource for microRNA-target
interactions. Nucleic acids Res. 37(Database issue): D105–D110.
2009. View Article : Google Scholar
|
|
19
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Palla G, Derényi I, Farkas I and Vicsek T:
Uncovering the overlapping community structure of complex networks
in nature and society. Nature. 435:814–818. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sumazin P, Yang X, Chiu HS, Chung WJ, Iyer
A, Llobet-Navas D, Rajbhandari P, Bansal M, Guarnieri P, Silva J
and Califano A: An extensive microRNA-mediated network of RNA-RNA
interactions regulates established oncogenic pathways in
glioblastoma. Cell. 147:370–381. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Adamcsek B, Palla G, Farkas IJ, Derényi I
and Vicsek T: CFinder: Locating cliques and overlapping modules in
biological networks. Bioinformatics. 22:1021–1023. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Alizadeh AA, Gentles AJ, Alencar AJ, Liu
CL, Kohrt HE, Houot R, Goldstein MJ, Zhao S, Natkunam Y, Advani RH,
et al: Prediction of survival in diffuse large B-cell lymphoma
based on the expression of 2 genes reflecting tumor and
microenvironment. Blood. 118:1350–1358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lossos IS, Czerwinski DK, Alizadeh AA,
Wechser MA, Tibshirani R, Botstein D and Levy R: Prediction of
survival in diffuse large-B-cell lymphoma based on the expression
of six genes. N Engl J Med. 350:1828–1837. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhou M, Wang X, Shi H, Cheng L, Wang Z,
Zhao H, Yang L and Sun J: Characterization of long non-coding
RNA-associated ceRNA network to reveal potential prognostic lncRNA
biomarkers in human ovarian cancer. Oncotarget. 7:12598–12611.
2016.PubMed/NCBI
|
|
26
|
Zhou M, Xu W, Yue X, Zhao H, Wang Z, Shi
H, Cheng L and Sun J: Relapse-related long non-coding RNA signature
to improve prognosis prediction of lung adenocarcinoma. Oncotarget.
7:29720–29738. 2016.PubMed/NCBI
|
|
27
|
Dhaini HR, Thomas DG, Giordano TJ, Johnson
TD, Biermann JS, Leu K, Hollenberg PF and Baker LH: Cytochrome P450
CYP3A4/5 expression as a biomarker of outcome in osteosarcoma. J
Clin Oncol. 21:2481–2485. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Trujillo-Paolillo A, Tesser-Gamba F,
Petrilli AS, de Seixas Alves MT, Garcia Filho RJ, de Oliveira R and
de Toledo SRC: CYP genes in osteosarcoma: Their role in
tumorigenesis, pulmonary metastatic microenvironment and treatment
response. Oncotarget. 8:38530–38540. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Niemeier A, Kassem M, Toedter K, Wendt D,
Ruether W, Beisiegel U and Heeren J: Expression of LRP1 by human
osteoblasts: A mechanism for the delivery of lipoproteins and
vitamin K1 to bone. J Bone Miner Res. 20:283–293. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tay Y, Kats L, Salmena L, Weiss D, Tan SM,
Ala U, Karreth F, Poliseno L, Provero P, Di Cunto F, et al:
Coding-independent regulation of the tumor suppressor PTEN by
competing endogenous mRNAs. Cell. 147:344–357. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cong C, Wang W, Tian J, Gao T, Zheng W and
Zhou C: Identification of serum miR-124 as a biomarker for
diagnosis and prognosis in osteosarcoma. Cancer Biomark.
21:449–454. 2018. View Article : Google Scholar
|
|
32
|
Jin H, Luo S, Wang Y, Liu C, Piao Z, Xu M,
Guan W, Li Q, Zou H, Tan QY, et al: miR-135b stimulates
osteosarcoma recurrence and lung metastasis via Notch and
Wnt/β-catenin signaling. Mol Ther Nucleic Acids. 8:111–122. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Sha B, Gao W, Han Y, Wang S, Wu J, Xu F
and Lu T: Potential application of titanium dioxide nanoparticles
in the prevention of osteosarcoma and chondrosarcoma recurrence. J
Nanosci Nanotechnol. 13:1208–1211. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Wang J, Cao L, Wu J and Wang Q: Long
non-coding RNA SNHG1 regulates NOB1 expression by sponging miR-326
and promotes tumorigenesis in osteosarcoma. Int J Oncol. 52:77–88.
2018.
|
|
35
|
Zhang R and Xia T: Long non-coding RNA
XIST regulates PDCD4 expression by interacting with miR-21-5p and
inhibits osteosarcoma cell growth and metastasis. Int J Oncol.
51:1460–1470. 2017. View Article : Google Scholar : PubMed/NCBI
|
